| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| L M Konopka, R Cooper, J W Crayto. Serotonin-induced increases in platelet cytosolic calcium concentration in depressed, schizophrenic, and substance abuse patients. Biological psychiatry. vol 39. issue 8. 1996-10-24. PMID:8731458. |
exaggerated intracellular calcium responses to challenges with serotonin (5-ht) have been reported in depression. |
1996-10-24 |
2023-08-12 |
Not clear |
| M Hamo. [New perspectives in the serotoninergic treatment for depression]. Therapie. vol 50. issue 6. 1996-10-24. PMID:8745948. |
furthermore, this neurobiological alteration very probably contributes to depression because treatments known to increase the 'serotonergic tone', such as the chronic administration of selective serotonin reuptake inhibitors (ssris), have antidepressant properties. |
1996-10-24 |
2023-08-12 |
Not clear |
| F G Graeff, F S Guimarães, T G De Andrade, J F Deaki. Role of 5-HT in stress, anxiety, and depression. Pharmacology, biochemistry, and behavior. vol 54. issue 1. 1996-10-23. PMID:8728550. |
role of 5-ht in stress, anxiety, and depression. |
1996-10-23 |
2023-08-12 |
human |
| F G Graeff, F S Guimarães, T G De Andrade, J F Deaki. Role of 5-HT in stress, anxiety, and depression. Pharmacology, biochemistry, and behavior. vol 54. issue 1. 1996-10-23. PMID:8728550. |
there are conflicting results on the function of 5-ht in anxiety and depression. |
1996-10-23 |
2023-08-12 |
human |
| W Pirker, S Asenbaum, S Kasper, H Walter, P Angelberger, G Koch, A Pozzera, L Deecke, I Podreka, T Brück. beta-CIT SPECT demonstrates blockade of 5HT-uptake sites by citalopram in the human brain in vivo. Journal of neural transmission. General section. vol 100. issue 3. 1996-10-23. PMID:8748670. |
spect measurements of serotonin uptake sites in patients with depression and other psychiatric disorders might provide better insights into the pathophysiology of these disorders and into mechanisms of drug action. |
1996-10-23 |
2023-08-12 |
human |
| L Bendtsen, R Jensen, J Olese. A non-selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache. Journal of neurology, neurosurgery, and psychiatry. vol 61. issue 3. 1996-10-17. PMID:8795600. |
in addition, the new selective serotonin reuptake inhibiting antidepressants, which are widely used in depression and of potential value in pain management, have never been investigated in a placebo controlled study of tension-type headache. |
1996-10-17 |
2023-08-12 |
Not clear |
| A J Cleare, A McGregor, V O'Kean. Neuroendocrine evidence for an association between hypothyroidism, reduced central 5-HT activity and depression. Clinical endocrinology. vol 43. issue 6. 1996-10-15. PMID:8736274. |
neuroendocrine evidence for an association between hypothyroidism, reduced central 5-ht activity and depression. |
1996-10-15 |
2023-08-12 |
Not clear |
| A J Cleare, A McGregor, V O'Kean. Neuroendocrine evidence for an association between hypothyroidism, reduced central 5-HT activity and depression. Clinical endocrinology. vol 43. issue 6. 1996-10-15. PMID:8736274. |
we tested the hypothesis that central 5-ht activity is reduced in hypothyroidism, and that this subsequently lowers the threshold for developing depression. |
1996-10-15 |
2023-08-12 |
Not clear |
| J F Deaki. Does selectivity matter? International clinical psychopharmacology. vol 11 Suppl 1. 1996-10-09. PMID:8732439. |
it is now clear that selective serotonin reuptake inhibitors (ssris) are more effective than noradrenaline reuptake inhibitors (naris) in the treatment of obsessional compulsive disorder, and obsessional features in depression predict a responsivity to ssris. |
1996-10-09 |
2023-08-12 |
human |
| H M Hochberg, D Kanter, V P House. Electrocardiographic findings during extended clinical trials of fluvoxamine in depression: one years experience. Pharmacopsychiatry. vol 28. issue 6. 1996-10-09. PMID:8773292. |
fluvoxamine, a selective serotonin reuptake inhibitor (ssri), is used to treat depression. |
1996-10-09 |
2023-08-12 |
Not clear |
| C Moret, M Brile. Effects of acute and repeated administration of citalopram on extracellular levels of serotonin in rat brain. European journal of pharmacology. vol 295. issue 2-3. 1996-09-26. PMID:8720583. |
this finding suggests that a 5-ht autoreceptor antagonist or a combination of such a drug with a 5-ht uptake inhibitor would produce a greater increase of extracellular levels of 5-ht in hyposerotonergic states such as depression. |
1996-09-26 |
2023-08-12 |
rat |
| D J Goldstei. Effects of third trimester fluoxetine exposure on the newborn. Journal of clinical psychopharmacology. vol 15. issue 6. 1996-09-26. PMID:8748430. |
prospectively identified fluoxetine-exposed pregnancies were evaluated to determine whether fluoxetine, a serotonin reuptake inhibitor commonly used for the treatment of depression and obsessive-compulsive disorder, might be associated with neonatal complications after maternal fluoxetine exposure during the third trimester through delivery. |
1996-09-26 |
2023-08-12 |
Not clear |
| A J Cleare, R M Murray, V O'Kean. Reduced prolactin and cortisol responses to d-fenfluramine in depressed compared to healthy matched control subjects. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 14. issue 5. 1996-09-12. PMID:8703303. |
d-fenfluramine, a specific 5-ht releasing agent without the catecholamine effects of d,l-fenfluramine, was used as a neuroendocrine challenge in 19 subjects with major depression and 19 healthy controls. |
1996-09-12 |
2023-08-12 |
human |
| N Sonino, G A Fav. Serotonin, Cushing's disease, and depression. Psychotherapy and psychosomatics. vol 65. issue 2. 1996-09-06. PMID:8711083. |
serotonin, cushing's disease, and depression. |
1996-09-06 |
2023-08-12 |
Not clear |
| B E Leonar. Serotonin receptors and their function in sleep, anxiety disorders and depression. Psychotherapy and psychosomatics. vol 65. issue 2. 1996-09-06. PMID:8711084. |
serotonin receptors and their function in sleep, anxiety disorders and depression. |
1996-09-06 |
2023-08-12 |
rat |
| R J Wurtman, J J Wurtma. Brain serotonin, carbohydrate-craving, obesity and depression. Obesity research. vol 3 Suppl 4. 1996-09-05. PMID:8697046. |
brain serotonin, carbohydrate-craving, obesity and depression. |
1996-09-05 |
2023-08-12 |
Not clear |
| P A Newhous. Use of serotonin selective reuptake inhibitors in geriatric depression. The Journal of clinical psychiatry. vol 57 Suppl 5. 1996-07-19. PMID:8647788. |
use of serotonin selective reuptake inhibitors in geriatric depression. |
1996-07-19 |
2023-08-12 |
Not clear |
| P A Newhous. Use of serotonin selective reuptake inhibitors in geriatric depression. The Journal of clinical psychiatry. vol 57 Suppl 5. 1996-07-19. PMID:8647788. |
the advent of the serotonin selective reuptake inhibitors (ssris) represents a significant advance in the treatment of depression. |
1996-07-19 |
2023-08-12 |
Not clear |
| R Kuze. Management of depression. Current trends in primary care. Postgraduate medicine. vol 99. issue 5. 1996-07-19. PMID:8650085. |
selective serotonin reuptake inhibitors are well tolerated and are considered by many to be the agents of choice in primary care treatment of depression because of their favorable adverse-effect profile. |
1996-07-19 |
2023-08-12 |
Not clear |
| G M Goodwi. How do antidepressants affect serotonin receptors? The role of serotonin receptors in the therapeutic and side effect profile of the SSRIs. The Journal of clinical psychiatry. vol 57 Suppl 4. 1996-07-09. PMID:8636065. |
the serotonin selective reuptake inhibitors (ssris) have proved to be an important development in the treatment of depression because of both their greater practical ease of use and their selective primary action on a single binding site. |
1996-07-09 |
2023-08-12 |
Not clear |